Trademark: 90319282
Word
EARN WITH PURPOSE
Status Date
Friday, August 9, 2024
Filing Date
Friday, November 13, 2020
Published for Opposition
Tuesday, June 14, 2022
40 Processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma for transplant purposes, medicinal purposes, and for use by others in scientific research, and the research and development of medicine, therapeutics, and pharmaceuticals; Treatment of materials, namely, treatment of blood and blood plasma for transplant purposes, medicinal purposes, and for use by others in scientific research, and the research and development of medicine, therapeutics, and pharmaceuticals
9 Downloadable mobile software application for use in scheduling appointments with blood plasma donation center for the collection of blood plasma, for tracking the associated compensation and incentive rewards associated with those appointments, for managing memberships associated with the blood plasma donation centers and those appointments, and for receiving news from blood plasma donation centers in the field of blood plasma donation and the use of blood plasma
35 Promoting the donation of blood and volunteer services and financial resources in the field of blood and human blood plasma donations by means of arranging and conducting incentive reward programs and compensation programs
44 Collection of human blood plasma; medical testing of human blood plasma for diagnostic or treatment purposes; blood bank services; medical screening of human blood plasma for diagnostic or treatment purposes; Blood plasma donation center services; Medical services, particularly the medical services of a blood donation center; Blood component collection services
42 Medical laboratory services, namely, testing and screening of human blood plasma for scientific research and development purposes; Medical laboratory services regarding human blood plasma; scientific research, and the research and development of medicine, therapeutics, and pharmaceuticals by means of processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; scientific research, and the research and development of medicine, therapeutics, and pharmaceuticals by means of treatment of blood and blood plasma
Jan 14, 2021
New Application Office Supplied Data Entered
Nov 17, 2020
New Application Entered
Apr 22, 2021
Assigned To Examiner
Apr 30, 2021
Non-Final Action Written
Apr 30, 2021
Non-Final Action E-Mailed
Apr 30, 2021
Notification Of Non-Final Action E-Mailed
Nov 1, 2021
Correspondence Received In Law Office
Nov 1, 2021
Teas Response To Office Action Received
Nov 2, 2021
Teas/Email Correspondence Entered
Nov 8, 2021
Final Refusal E-Mailed
Nov 8, 2021
Notification Of Final Refusal Emailed
Nov 8, 2021
Final Refusal Written
May 9, 2022
Examiners Amendment -Written
May 9, 2022
Examiners Amendment E-Mailed
May 9, 2022
Notification Of Examiners Amendment E-Mailed
May 9, 2022
Examiner's Amendment Entered
May 9, 2022
Approved For Pub - Principal Register
May 25, 2022
Notification Of Notice Of Publication E-Mailed
Jun 14, 2022
Published For Opposition
Feb 9, 2023
Sou Teas Extension Received
Feb 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 9, 2023
Sou Teas Extension Received
Jun 14, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 9, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 9, 2023
Sou Extension 1 Filed
Feb 9, 2023
Sou Extension 1 Granted
Aug 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 9, 2023
Sou Extension 2 Filed
Aug 9, 2023
Sou Extension 2 Granted
Feb 9, 2024
Sou Extension 3 Filed
Mar 11, 2024
Petition To Revive-Granted
Mar 11, 2024
Notice Of Revival - E-Mailed
Mar 11, 2024
Teas Petition To Revive Received
Mar 11, 2024
Sou Extension Received With Teas Petition
Mar 11, 2024
Abandonment - No Use Statement Filed
Mar 11, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 11, 2024
Teas Petition To Revive Received
Mar 11, 2024
Notice Of Revival - E-Mailed
Apr 29, 2024
Case Assigned To Intent To Use Paralegal
Apr 29, 2024
Sou Extension 3 Granted
Aug 9, 2024
Sou Teas Extension Received
Aug 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 9, 2024
Sou Extension 4 Granted
Aug 9, 2024
Sou Extension 4 Filed
Apr 30, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
